GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


PRINCIPLES OF LABELLING


OBJECTIVES

The objective of this course is to provide you with an overview of the safety communication processes and the safety risk management approach, including the safety label change process.

You will also

  •  Develop an awareness of safety data and its influence and impact on product labelling
  •  Develop knowledge and understanding of the practical implications of European regulations and guidance concerning labelling
  •  Understand the principles determining the content of the Investigator Brochure (IB) and Summary of Product Characteristics (SmPC)
  •  Become familiar with analysis and management of an emerging risk by amendments to product labelling

Labelling, safety label, Investigator Brochure, Summary of Product Characteristics, Safety risk management, Safety communication processes, CCDS, SmPC, PL(PIL)

 

LEARNING OUTCOMES

At the end of this course,

You will gain understanding of the scope and responsibilities of decision boards involved in managing drug safety and will understand why protecting patient safety also helps protect the pharmaceutical industry.

Besides, you will have knowledge and understanding of CCDS, SmPC, PL(PIL) and the labelling process for investigational drugs undergoing clinical trials.

 

180 minutes
Online based learning
English language
Certificate of Achievement
300 €
REGISTER NOW

AUTHORS

avatar

Dr. Sherael Webley

University of Hertfordshire

avatar

Dr. David Lewis

Global head of Pharmacovigilance
Novartis Pharma AG




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners